Clomiphene citrate (CC) therapy for disorders of anovulatory infertility has been linked to an increased frequency of tubal ectopic pregnancy. Although CC enhances apoptotic processes in the ovaries, villi, and decidual tissues, its effect on apoptosis in the fallopian tube is unknown. Here, we show that chronic treatment with CC induces tubal apoptosis, but not necrosis, through an intrinsic mitochondria-dependent signaling pathway in vivo. The apoptosis was specific to epithelial cells in the isthmus, and the damage was reversed with 17beta-estradiol (E2); however, pretreatment or concomitant treatment with E2 did not protect against tubal apoptosis induced by chronic treatment with CC. Chronic treatment activated estrogen receptors (ESRs), particularly cilia-localized ESR2A (formerly ERbeta2). In contrast to E2, acute treatment of superovulating rats with a high dose of CC or the ESR2-selective agonist 2,3-bis (4-hydroxyphenyl)-propionitrile (DPN) significantly delayed the transport of oocyte-cumulus complexes through the fallopian tube. Our findings suggest that in response to chronic CC therapy, isthmus-specific apoptosis of epithelial cells and activation of cilia-ESR2A act in parallel to block gamete and embryo passage through the fallopian tube, eventually resulting in tubal ectopic pregnancy.
INTRODUCTION
The mammalian fallopian tube (oviduct or uterine tube) is a dynamic, steroid-responsive tissue that facilitates fertilization of the gamete and early embryo transport, which are essential for normal pregnancy [1] . Abnormalities in the structure and function of the fallopian tube could interfere with the transport process, leading to tubal ectopic pregnancy, a common and potentially life-threatening reproductive disease. The molecular mechanism of this interference is not well characterized, in part because of the lack of suitable animal models [2] .
Clomiphene citrate (CC), a nonsteroidal, tissue-selective estrogen receptor modulator (SERM) [3] [4] [5] , is used to treat anovulatory infertility, particularly polycystic ovarian syndrome [6] [7] [8] , and is the drug of choice for ovulatory women undergoing in vitro fertilization [9] . Although CC has limited dose-dependent side effects, prolonged treatment is associated with an increased frequency of tubal ectopic pregnancy in humans [10] [11] [12] , raising the possibility such treatment causes fallopian tube abnormalities. Therefore, elucidating the molecular and cellular mechanisms for the fallopian tube-specific effects of CC is important for enhancing its therapeutic efficacy against infertility and preventing adverse effects.
Clomiphene citrate has antagonistic activity on estrogen/ estrogen receptor (ESR) signaling in female reproductive tissues, including rodent ovary [13, 14] , chicken fallopian tube [15] , and human endometrium [16] [17] [18] [19] , and it acts as a strong agonist in nonreproductive tissues, such as bone and liver [20] . In rats, CC induces apoptosis of ovarian granulosa cells that can be rescued by 17b-estradiol (E2) in vivo [21, 22] . These findings suggest that CC acts as an ESR antagonist that regulates apoptosis in the tissue and cellular targets of estrogen signaling. Apoptotic changes in human chorionic villi and decidual tissues may increase the risk of tubal ectopic pregnancy [23] . However, CC causes ovarian and uterine abnormalities [22, 24] , and it might have adverse effects on the fallopian tube or on apoptotic signaling pathways in this tissue.
In this study, we assessed the effects of acute and chronic treatment of rats with CC, with the goal of determining whether CC induces apoptosis in the fallopian tube. We also sought to determine which apoptotic pathway might be involved and whether CC affects cell type-specific regulation of ESR subtypes in the fallopian tube. Finally, we assessed the effects of CC on migration of oocyte-cumulus complexes (OCCs) in superovulating rats.
MATERIALS AND METHODS

Experimental Animals
All experimental procedures and protocols were approved by the ethics committee at Gothenburg University. Prepubertal female Sprague-Dawley rats (21 days old) were obtained from Taconic M&B (Copenhagen, Denmark) and maintained in polycarbonate plastic cages containing wood chips under defined conditions (a temperature of 218C 6 28C, a relative humidity of 45%-55%, and 12L:12D illumination schedule) at an infection-free animal facility. All animals had free access to tap water and were ad libitum fed with standard laboratory chow (Teklad global 16% protein rodent diet, 2016; Harlan). Diet 2016 does not contain alfalfa or soybean meal, thus minimizing the occurrence of natural phytoestrogens.
CC and E2 Treatment, Experimental Design, and Tissue Preparation
Three experiments were carried out ( Fig. 1 ) in 25-day-old rats. The rats were randomized to receive i.p. injections of CC (Sigma-Aldrich, St. Louis, MO), E2 (Sigma-Aldrich), or both. Controls were treated with vehicle only. Rats were killed under light anesthesia with sodium pentobarbital (0.5 ml/kg body weight). Aliquots of serum were prepared from trunk blood after heart puncture and stored at À808C until analysis. Body weight was recorded throughout the experiment. After dissection, fallopian tube tissues were weighed and immediately frozen in liquid nitrogen or fixed in formalin. Experiment 1. Rats received CC (1 or 10 mg/kg i.p.) or an equivalent volume of vehicle (0.9% NaCl). Fallopian tubes were collected 6 and 24 h (acute effect) after the injection or on Day 4 (chronic effect) after once-daily i.p. injection (n ¼ 8 per group). At the selected doses and treatment schedule, CC is effective in rat ovary, uterus, and bone in vivo [21, 25, 26] .
Experiment 2. Rats received injections of CC (10 mg/kg i.p.) or vehicle (0.9% NaCl) once daily for 4 consecutive days. Twenty-four hours after the last injection, E2 (0.3 mg/kg in 100 ll of sesame oil) or vehicle was injected for 4 consecutive days. The rats were killed, and fallopian tubes were collected 24 h after the last injection (n ¼ 5 per group).
Experiment 3. Rats were injected with E2 or vehicle once daily for 4 consecutive days, as in experiment 2. Twenty-four hours after the last injection, CC (10 mg/kg), CC (10 mg/kg) and E2 (0.3 mg/kg), or vehicle (0.9% NaCl and sesame oil) was injected i.p. for 4 consecutive days. The rats were killed, and fallopian tubes were collected 24 h after the final injection (n ¼ 5 per group).
Superovulation, Drug Treatment, and Tissue/Cell Collection Superovulation was induced in 25-day-old female rats by subcutaneous injection of equine gonadotropin (10 IU; Sigma-Aldrich) and, 48 h later, i.p injection of human chorionic gonadotropin (hCG; 50 IU; N.V. Organon, Oss, Holland) to mimic the endogenous luteinizing hormone surge. In rodents, ovulation occurs 12-14 h after hCG treatment [27] .
To determine whether a single dose of CC influences oocyte transport, superovulating rats received an i.p. injection of CC (1 or 10 mg/kg), E2 (0.3 mg/kg), the ESR2-selective agonist 2,3-bis (4-hydroxyphenyl)-propionitrile (DPN; 10/100/250 mg/kg; Tocris Cookson, Bristol, UK) [28] , the ESR1-selective agonist 4,4 0 ,4-(4-prophl-[1H]-pyrazole-1,3,5-triyl) trisphenol (PPT; 100 mg/kg; Tocris Cookson) [29] , or vehicle 6 h after hCG injection. Doses and sample times were based on previously published reports [30] [31] [32] .
Fallopian tubes were dissected, and the ova were examined under a dissecting microscope at 14, 24, 30, 36, and 48 h after hCG injection. The enlarged and translucent ampulla of each fallopian tube was excised and trimmed, and ovulated OCCs were collected into PBS, centrifuged, and stored at À808C until use for Western blot analysis.
RNA Extraction and Quantitative RT-PCR
Total cellular RNA from the fallopian tubes of each rat was isolated with the RNeasy Micro Kit (Qiagen) and treated with RNase inhibitor (Applied Biosystems, Foster City, CA). Single-stranded cDNA was synthesized from each sample (0.5 lg) with High-Capacity cDNA Reverse Transcription kits (Applied Biosystems). Quantitative real-time RT-PCR (q-RT-PCR) was performed with an ABI PRISM 7000 sequence detection system and TaqMan gene expression products (Applied Biosystems) for Fas (assay ID: 00594913_m1), Bcl2 (assay ID: Rn99999125_m1), and Bax (assay ID: Rn01480160_g1) and, as loading controls, ACTB (4352340E) and GAPDH (4308313). All reactions were conducted in duplicate, and each included a nontemplate control. Duplicate CT values were analyzed with the comparative CT (DDCT) method (Applied Biosystems). The validity of the above assumption was verified for each primer set by serial cDNA dilutions. The amount of target (2 -DDCT) was obtained by normalizing to b-actin relative to a calibrator (one control sample) and expressed as the fold difference from the control group.
Antibodies
The primary antibodies used for immunofluorescence, immunohistochemistry, and Western blot analysis are listed in Table 1 . Cy3-conjugated antimouse antibody (715-166-150), biotin-conjugated anti-rabbit antibody (711-066-152), and streptavidin conjugated with fluorescein (DTAF; 016-010-084) were from Jackson ImmunoResearch Laboratories (West Grove, PA). Texas Red anti-rabbit antibody (TI-1000) was from Vector Laboratories (Burlingame, CA). The secondary antibodies in the Western blot analysis were goat-antimouse immunoglobulin G (IgG; A-1682; Sigma-Aldrich) and goat-anti-rabbit IgG (AC31RL; Tropix, Bedford, MA), both conjugated with alkaline phosphatase. Normal goat serum was from Dako (Carpinteria, CA).
Histologic Evaluation
The fallopian tubes were dissected, fixed in neutral-buffered 10% formalin, decalcified, dehydrated, and embedded in paraffin. Sections (5 lm) were prepared and stained with hematoxylin and eosin to visualize cellular nuclei (Histocenter, Skandinaviskt Centrum fö r Histoteknik, Västra Frö lunda, Sweden).
Immunohistochemistry and Immunofluorescence Staining
Immunohistochemistry and immunofluorescence studies were performed to localize TUBB4, CYCS, and activated CASP3 in the fallopian tube as described previously [31, 33] . Ciliated epithelial cells stained for TUBB4 were detected by biotin-streptavidin-peroxidase staining (Elite kit; Vector Laboratories). TUBB4-positive ciliated epithelial cells in random cross-sections from different regions of the fallopian tube (n ¼ 5 rats/group) were counted, in blinded fashion, at 403 magnification. At this magnification, the presence or absence of ciliated epithelial cell staining was unambiguous. The number of labeled cells was expressed as the percentage of total epithelial cells, and mean percentages were calculated for each group.
Protein Extraction and Western Blot Analysis
Whole-cell extracts from tubal tissues were analyzed by Western blot essentially as described previously [31, 33] . The dilutions of each antibody are indicated in Table 1 . Corresponding nonspecific IgGs were used as negative control and processed in parallel. In experiments in which cleaved CASP9, cleaved CASP3, and ZP3 were assessed, the gel was cut into two pieces along a line corresponding to approximately 51 kDa. The section containing higher molecular weights was exposed to the anti-ZP3 antibody, and the lowermolecular weight section was exposed to anti-CASP9 or anti-CASP3 antibody. To reprobe the blot with another antibody, the blot was rehydrated in methanol, rinsed, and incubated with stripping buffer (65 mM Tris-HCl, 2% SDS, and 100 mM b-mercaptoethanol, pH 6.8) at 508C for 30 min. Immunoblotted signals were visualized using an LAS 1000-cooled, charge-coupled device camera (Fujifilm) and ECL film (Amersham International). Individual bands were quantified directly from membranes by densitometry using the ImageQuant (version 5.0) software program (Molecular Dynamics, Sunnyvale, CA). Signal 
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intensities of the individual protein were normalized to the gels stained with Coomassie blue and presented as ratios that represent arbitrary densitometric units (ADU) of relative abundance.
Caspase Activity Assay
To measure CASP3/7 activity in whole fallopian tube, the frozen tissue was homogenized in a lysis buffer (100 mM HEPES, pH 7.4, 140 mM NaCl, and the protease inhibitors), and the crude homogenate was centrifuged at 12 000 3 g for 30 min at 48C. Cellular caspase activity was determined by the CaspaseGlo 3/7 assay kit as described previously [34] . Ovarian tissues from immature rats were used as positive controls.
Assessment of Circulating Hormones
Estradiol, progesterone, and testosterone levels were determined with radioimmunoassay kits (Perkin-Elmer Life and Analytical Sciences, Turku, Finland).
Statistical Analysis
Data were analyzed with SPSS (version 13.0; SPSS, Chicago, IL). Twoway ANOVA was used to assess the main effects of treatment and time and to identify interactions between them. If significant interactions between the fixed factors were observed, within-group analyses were performed with a one-way ANOVA followed by Bonferroni multiple-comparison test. Values are presented as mean 6 SEM. Significance was accepted at the 0.05 level of probability.
RESULTS
Effects of CC Treatment on Body Weight, Fallopian Tube Wet Weight, and Steroid Hormone Levels
As shown in Table 2 , body weight and progesterone levels were unaffected by acute (6-and 24-h) or chronic (4-day) treatment with low-dose or high-dose CC (1 or 10 mg/kg). Fallopian tube weight was increased by high-dose acute treatment and chronic treatment at both doses. Estradiol levels were significantly increased by chronic CC treatment, consistent with findings in humans [35] [36] [37] [38] and rats [21, 39] . Clomiphene citrate also increased testosterone levels, regardless of dose or treatment schedule. Percentage body weight is given in parentheses. z P , 0.05 effect of treatment (two-way ANOVA). § P , 0.05 versus vehicle (Bonferroni post hoc test after significant two-way ANOVA time and treatment interaction). jj P , 0.05 versus vehicle (Bonferroni post hoc test after significant two-way ANOVA time and treatment interaction).
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Chronic but Not Acute CC Treatment Induces Tubal Apoptosis
To investigate the effects of CC on tubal apoptosis, we measured the mRNA expression of the apoptosis-related molecules Fas, Bcl2, and Bax in fallopian tissue by q-RT-PCR. Bcl2 mRNA expression was significantly decreased by CC treatment at 24 h and 4 days, and Bax expression was significantly increased after 4 days of treatment, resulting in an overall decrease in Bcl2:Bax ratio at both time points. Fas mRNA levels were unaffected ( Fig. 2A) .
To determine whether CC-induced changes in Bcl2 and Bax were accompanied by alterations in caspase activation, we analyzed fallopian tissue by Western blot analysis for CASP8 and CASP9 (initiators) and CASP3 (executioner). Clomiphene citrate did not alter the level of cleaved CASP8, and acute treatment did not alter the levels of cleaved CASP9 or CASP3. After chronic treatment for 4 days, however, the levels of cleaved CASP9 and CASP3 increased significantly (Fig. 2B) . The effects of CC on tubal expression of proapoptotic and antiapoptotic genes and proteins were dose independent. The pattern of cleaved CASP3 protein expression was consistent with CASP3/7 activity (data not shown). These findings suggest that CC induces tubal apoptosis by regulating proapoptotic and antiapoptotic genes and activating the caspase cascade.
CC Causes Regional, Cell Type-Specific Apoptosis in the Fallopian Tube
To explore the morphologic and histological effects of CCinduced changes in apoptotic pathways, we analyzed CYCS and cleaved CASP3 by immunofluorescence staining in successive sections of the fallopian tube. In rats treated with CC for 4 days, positive staining for both mitochondrial CYCS and cleaved CASP3 was detected in the isthmus (Fig. 3, A4 and B4) but not in the ampulla (Fig. 3, A3 and B3) or infundibulum (data not shown); staining within the isthmus was restricted specifically to the epithelial cell layers and was absent in smooth muscle cells (Fig. 3, A4 and B4) . In control rats, CYCS (Fig. 3, A1 and A2) and cleaved CASP3 (Fig. 3,  B1 and B2) were not detected.
E2 Aids Recovery from CC-Induced Tubal Apoptosis but Is Not Protective
In prepubertal rats, the fallopian tube consists of relatively undifferentiated cuboidal and specialized secretory epithelial
-dependent mechanism. Rats were treated with CC for 6 or 24 h or 4 consecutive days (4 d; shaded area), and fallopian tubes were dissected. A) Quantitative real-time RT-PCR analysis of Fas, Bcl2, and Bax mRNA relative (re:) to endogenous ACTB (b-actin; n ¼ 5 rats per group). B) Western blot analysis of cleaved CASP8, CASP9, and CASP3 relative to whole protein. Gels were stained with Coomassie blue (n ¼ 3 rats per group). ACTB served as a loading control. Values are mean 6 SEM. *P , 0.05, **P , 0.01, and ***P , 0.001 versus vehicle-treated controls.
cells. Histological analysis of fallopian tissue revealed differentiation (from cuboidal to columnar morphology), hypertrophy, and hyperplasia of luminal epithelial cells in the isthmus in rats treated with CC for 4 days (Fig. 4A2) but not in controls (Fig. 4A1) . Disorganized epithelial cells in the isthmus were observed in CC-treated rats but not in E2-treated rats (Fig.  4A3) , indicating different effects of CC and E2 on epithelial cell morphology. Acute CC treatment failed to produce significant histological changes in the fallopian tube (data not shown). To determine whether E2 might contribute to recovery from CC-induced tubal apoptosis, rats were sequentially treated with E2 or vehicle for 4 days after chronic treatment with CC. Cleaved CASP3 levels were decreased in fallopian tubes from the E2-treated rats (Fig. 4B) , suggesting recovery from CCinduced apoptosis. More specifically, the expression of cleaved CASP3 protein closely paralleled the activity of CASP3/7 (Fig.  4D) . These findings were confirmed by immunostaining (data not shown). However, 4 days of pretreatment with E2 did not block CC-induced expression of cleaved CASP3, and cleaved CASP3 was even more abundant after concomitant E2 plus CC treatment than after CC treatment alone (Fig. 4C) , which corroborated with the findings for CASP3/7 activity (Fig. 4E ).
Chronic Treatment with CC Activates ESR Subtypes in the Fallopian Tube
Next, we examined by Western blot analysis the effects of chronic CC treatment on the expression and activation of ESR1 and ESR2 in the fallopian tube. ESR1 levels were unaffected, but ESR2A (formerly ERb2) levels were markedly increased (Fig. 5A) . Because the stability and activity of ESR subtypes are affected by ligand-dependent ESR phosphorylation [40] , it is important to note that chronic treatment with CC significantly increased the phosphorylation of both ESR1 and ESR2A (Fig. 5A) . Thus, the balance between ESR1 and ESR2A activities in the fallopian tube may mediate differences in sensitivity to CC.
Previously, we showed that ESR2A (formerly ERb2) is the dominant ESR2 isoform in rodent fallopian tubes, with both expression limited to motile cilia [31, 33] and colocalization with TUBB4, a cellular marker for cilia [41] (Fig. 5B) . Immunohistochemical staining showed that chronic treatment with CC did not affect the number of TUBB4-positive cells (Fig. 5C) . Thus, the induction of ESR2A expression with chronic CC treatment likely reflects increased protein expression rather than an increased number of cilia.
Acute Treatment with CC Slows OCC Transport in the Fallopian Tube
Because cilia are critical in gamete and embryo transport [42] , we hypothesized that CC influences the transport of OCCs by altering the function of ESR2 receptors in the cilia. To test this hypothesis, we stimulated ovulation in prepubertal rats with gonadotropins and then treated them with E2, CC, DNP [28] , PPT [29] , or vehicle. Consistent with previous findings [43, 44] , E2, a nonselective and, presumably, the most potent natural ligand for both ESRs, significantly increased the speed of OCC transport, and low-dose CC treatment had no effect; however, whereas the ESR1-selective agonist PPT enhanced OCC transport, high-dose CC and the ESR2-selective agonist DPN at 100 or 250 mg/kg significantly delayed OCC transport ( Table 3 ), indicating that two ESR subtypes play distinct roles in the OCC transport and that CC can affect gamete transport in the fallopian tube by modulating cilia-localized ESR2 activity.
Acute Treatment with CC Does Not Cause Apoptosis in Oocytes During OCC Transport
Both ESR subtypes are expressed in human and mouse oocytes and embryos [45] [46] [47] . To determine whether acute treatment with CC influences oocyte apoptosis and ESR subtype expression during OCC transport, we examined OCCs exposed to high-dose CC during the transport study for markers of apoptosis by Western blot analysis. First, we confirmed expression of ZP3, an oocyte marker, in ovarian sections by immunofluorescence staining (Fig. 6A) . Clomiphene citrate did not affect the levels of cleaved CASP9 or cleaved CASP3 in CC-treated OCCs relative to ZP3 expression levels (Fig. 6B) .
DISCUSSION
Tubal ectopic pregnancy has long been recognized as a common, life-threatening disorder [48, 49] , yet the mechanisms are still not fully understood. Because chronic CC therapy for anovulatory infertility increases the risk of tubal ectopic pregnancy [10] [11] [12] , we investigated the molecular and cellular processes underlying this phenomenon. The notion that chronic treatment with CC in rats induces apoptosis of tubal epithelial cells in the isthmus through a mitochondria-dependent signaling pathway was obvious. We found that E2 enabled recovery from the apoptotic damage but was not protective. Chronic treatment also activated ESRs, particularly cilia -FIG. 4 . Estradiol treatment enables recovery from CC-induced tubal apoptosis but is not protective. A1-A3) Hematoxylin and eosin staining of fallopian tube isthmus from rats treated with CC (10 mg/kg), E2 (0.3 mg/ kg), or vehicle for 4 consecutive days (d). cub, cuboidal epithelial cells; col, columnar epithelial cells. Rats were treated with E2 after (B) or before (C) 4 days (4 d) of CC treatment. Western blot analysis was used to measure cleaved CASP3 protein levels relative to whole protein. Gels were stained with Coomassie blue. ACTB served as a loading control. CASP3/7 activity was measured in whole fallopian tubes of rats treated with CC and/or E2 (D and E). Values are mean 6 SEM (n ¼ 5 rats per group). ***P , 0.001 vs. E2-treated rats. RLU, relative luminescence units. (1) 100 (5) 100 (10) 100 (5) 70 (10) 0 (10) CC (10) 100 (5) 100 (10) 100 (5) 100 (10) 40 ( (100) 80 (5) 100 (8) 100 (5) 100 (8) 20 ( 
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localized ESR2A (formerly ERb2) and, at high doses, it slowed OCC transport through the fallopian tube. These findings suggest that chronic CC therapy induces isthmus-specific apoptosis of epithelial cells and activates cilia-ESR2, which act in parallel to block gamete and embryo passage through the fallopian tube, eventually resulting in ectopic pregnancy.
Chronic Treatment with CC Induces Fallopian Tube Apoptosis
Chronic treatment of rats with CC caused tubal epithelial cell apoptosis in the isthmus but not in the ampulla, where most tubal ectopic pregnancies occur in humans. This apoptotic effect was dose independent. To clarify the cellular mechanisms, we analyzed the expression of several potential regulators of apoptosis in tubal tissues by q-RT-PCR, Western blot, and immunofluorescence analyses. CYCS, BAX, and CASP3 and CASP9 were upregulated, BCL2 was downregulated, and FAS and CASP8 were unchanged, indicating involvement of the intrinsic mitochondrial apoptotic pathway rather than the FAS-mediated extrinsic apoptotic pathway [50] . Because cellular apoptosis is closely related to necrosis, which often coincides with inflammation [50, 51] , we measured proinflammatory markers in the fallopian tube. Chronic CC treatment did not affect the expression of interleukin 6, interleukin 1a/b, or tumor necrosis factor a/b (data not shown), indicating that it did not induce necrotic cell death. Treatment with E2 enabled the rats to recover from apoptosis, suggesting a potential therapy for CC-induced tubal damage. Ovaryderived E2 is a key steroid hormone modulating mammalian fallopian tubal function [1] , and mounting evidence suggests that E2 can protect reproductive tissues and cell types from apoptosis. For example, E2 inhibits apoptotic cell death of ovarian granulosa cells [52, 53] and uterine epithelial cells [54] , and removal of endogenous E2 induces apoptosis in the fallopian tube [55, 56] , uterus [57] , and endometrial cells in vitro [58] . However, pretreatment or concomitant treatment with E2 did not protect against CC-induced apoptosis. Clomiphene citrate antagonizes endoplasmic reticulum-mediated, classic genomic actions of estrogens. The evident lack of protective effect of E2 in the present study could be explained by the fact that CC is able to display a much stronger antiestrogenic activity in the presence of E2-stimulated rat uterus [59] .
It is possible that an unidentified CC-response mechanism contributes to the tubal apoptosis we observed. After CC treatment, circulating testosterone levels increase in parallel with a decrease in androgen receptor (AR) expression in the fallopian tube (our unpublished observations). Dihydrotestosterone, a potent androgen, has similar effects [60] . In rats, estrogen exposure has been linked to AR expression and activation in epithelial cells in the fallopian tube and uterus [60, 61]. Thus, identification of other factors may provide clues to the molecular mechanism of CC-induced tubal apoptosis.
It is unclear why the apoptosis was limited to the isthmus, where epithelial cells were hypertrophied and disorganized, consistent with an altered apoptotic process and with previous morphological evaluations in human and rat fallopian tube after treatment with CC [24, 62] . Normally, apoptosis is rare in rodent fallopian tubes. We found no expression of cleaved CASP3 or CASP3/7 activity in the isthmus during normal reproductive cycles in humans (our unpublished observations). Moreover, the effects of CC have been studied primarily in ovary, uterus, and bone [21, 25, 26] ; their effects on the fallopian tube in humans have not been investigated. However, destruction of the tubal epithelial cell layers and impairment of epithelial cell function have been suggested as a cause of tubal ectopic pregnancy in humans [49] . Our findings indicate ectopic pregnancy may be caused by blockage of gamete and embryo transport through the fallopian tube as a result of CCinduced changes in the isthmus.
Activation of Cilia-Localized ESR2 by CC Retards OCC Transport in the Absence of Apoptosis
Through effects on ESR activation, CC had a direct antiestrogenic effect on the fallopian tube. The cellular responsiveness or susceptibility to estrogens is mediated principally by two ESR subtypes-ESR1 and ESR2-in estrogen-sensitive target tissues/cells [40] , including the fallopian tube [63] . The distinct localization and regulation of ESR subtype expression in the rodent fallopian tube [31, 33] suggest subtype-specific functions. Mammalian fallopian tube is thought to contain two epithelial cell types-ciliated and secretory [42] -and ciliary beating is thought to regulate gamete and embryo transport [64, 65] . The densest population of ciliated epithelial cells was found in the infundibulum and ampulla (Fig. 5B) , which did not undergo epithelial cell apoptosis after chronic CC treatment. Because the ESR2A is predominantly colocalized to TUBB4-positive cilia in these regions [31, 33] , and its expression was increased by chronic CC treatment, it may protect cilia from apoptosis. Consistent with this possibility, CYCS and cleaved CASP3 levels were unaltered in the infundibulum and ampulla. Thus, regulation of cilia-localized ESR2 (especially ESR2A) activation by CC may slow OCC transport through the fallopian tube in the absence of tubal apoptotic effects. This possibility is supported by two observations. First, treatment with CC for both 24 h (data not shown) and 4 days (Fig. 5A ) increased ESR2A expression and phosphorylation. Second, high-dose treatment with CC mimicked the ability of DPN, an ESR2-selective agonist, to slow OCC transport. This information will be useful for analyzing gamete transport under physiological and pathological conditions, such as tubal ectopic pregnancy.
Low-dose CC did not slow the transport of OCCs through the fallopian tube. One explanation for this finding is that we were simply unable to detect a change within the 48-h period we analyzed. Another possibility is that the CC concentrations were insufficient to stimulate cilia, and thus were below the threshold for effects on OCC transport. Further studies are needed to understand how various doses of CC act upon tubal cells to regulate OCC transport.
The execution of the biological effects of SERM is mediated by two ESRs: ESR1 and ESR2. Both ESRs have similar DNAand ligand-binding properties but differ in their transcriptional properties in vitro [66, 67] . Clomiphene citrate has a much lower ESR-binding affinity than E2 [5] . This difference may serve a biological function by enabling differential activation of the ESR1 and ESR2 signaling pathways. Because ESR1 is expressed in smooth muscle as well as epithelial cells in the fallopian tube [31, 33] , CC could have widespread effects on gamete transport by altering ESR1 activation in tubal cells. Indeed, in rat fallopian tube, ESR1 is strongly involved in estrogenic regulation of OCC transport [44] . However, the role of CC-induced tubal ESR1 activation in this process remains unclear. Because CC has been shown to bind to both ESR1 and ESR2 with approximately similar affinities (effective concentration at 50% ¼ 120) in vitro [68] , it is difficult to determine whether tubal ESR subtypes are either coordinately or independently responsible for CC-accelerated OCC transport, but the fact that PPT and DPN had opposing effects is consistent with the ying-yang role for ESR1 and ESR2 in CCretarded OCC transport that was proposed by Lindberg et al. [69] . Because both receptors are expressed in human and mouse oocytes and embryos [45] [46] [47] , and CC induces oocyte and embryo degeneration [70, 71] , we suspected that CC might modulate oocyte survival during OCC transport. However, acute, high-dose CC treatment did not cause oocyte apoptosis. FIG. 6 . Acute treatment with CC does not regulate apoptosis during OCC transport. A) Immunofluorescence staining for the oocyte marker ZP3 (red; left) in the ovary of prepubertal rats (25 days old). Sections were counterstained with DAPI to visualize cell nuclei (blue; right). B) Ovulated OCCs were collected from superovulating rats treated with CC (10 mg/kg) or vehicle 24 or 36 h after treatment with hCG. Western blot analysis was used to measure cleaved CASP9, cleaved CASP3, and ZP3 in the OCCs. The experiment was performed using different OCC preparations, with similar results. Positive controls for cleaved CASP9, cleaved CASP3, and ZP3 included homogenates of ovarian granulosa cells (GCs) isolated from prepubertal rats treated with or without equine chorionic gonadotropin.
In conclusion, chronic treatment with CC caused severe fallopian tube disruption and apoptosis, which was specific to the isthmus and opposed by E2, and slowed transport of OCCs. ESR2 (especially ESR2A) expression and activation in cilia were altered before the onset of CC-induced tubal apoptosis, suggesting a mechanism for CC-induced tubal ectopic pregnancy. Because CC is administered at relatively high doses (25-200 mg daily for 5-10 days) to women with anovulatory infertility [3, 4] , such treatment might cause massive apoptosis of isthmic epithelial cells. Our findings suggest that such damage can be reversed with E2. It is not yet known how CC distinctly regulates ESR1 and ESR2 in the fallopian tubes. Further investigation will be required to evaluate the clinical implications of our findings, to determine whether CC elicits tubal apoptotic changes in humans by the same mechanism, and to identify CC-responsive target genes within isthmic epithelial cells.
